Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002;90:1237-1239
doi: 10.1161/01.RES.0000025101.04065.83
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bishopric, N. H.
Right arrow Articles by Webster, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bishopric, N. H.
Right arrow Articles by Webster, K. A.
Related Collections
Right arrow Pathophysiology
Right arrow Cell signalling/signal transduction
Right arrow Growth factors/cytokines
(Circulation Research. 2002;90:1237.)
© 2002 American Heart Association, Inc.


Editorials

Preventing Apoptosis With Thioredoxin

ASK Me How

Nanette H. Bishopric, Keith A. Webster

From the Departments of Pharmacology (N.H.B., K.A.W.) and Medicine (N.H.B.), University of Miami School of Medicine, Miami, Fla.

Correspondence to Nanette H. Bishopric, MD, FACC, Associate Professor of Pharmacology and Medicine, University of Miami School of Medicine, PO Box 016189 (R-189), Miami, FL 33101. E-mail n.bishopric@miami.edu


Key Words: reactive oxygen species • apoptosis signal-regulating kinase 1 • thioredoxin


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Reactive oxygen species (ROS) are critical signaling molecules in eukaryotic cells, regulating growth, survival, and death pathways. High concentrations of ROS are cytotoxic, but low concentrations can promote growth and activate critical signal pathways in many cell types.1 In the cardiovascular system, significant amounts of ROS are generated as byproducts of mitochondrial metabolism and may increase to toxic levels in the myocardium during and after periods of reduced blood flow. In addition, a number of extracellular peptide hormones are able to increase the production of ROS through receptor-mediated stimulation of membrane-bound NADPH oxidase.2,3 The hypertrophic effects of angiotensin II4 and more recently other G protein–coupled receptor (GPCR) agonists5 have been shown to involve the generation of ROS through this mechanism. In addition, many apoptotic stresses in the cardiac myocyte, including ischemia-reperfusion and high concentrations of NO, signal through ROS. Oxidative stress is a central component of the mitochondrial permeability transition in cardiac myocytes, and the latter seems to underlie most pathologically relevant examples of cardiac myocyte apoptosis in vivo.6 Consequently, a clear understanding of the relationship between myocardial growth and apoptosis signaling will require a better understanding of the intracellular signals that respond to ROS.

In this issue of Circulation Research, Liu and Min7 shed light on a fascinating redox-sensitive mechanism that can generate both apoptotic and hypertrophic signals in the cardiovascular system. Apoptosis signal-regulating kinase 1 (ASK1), a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family, is an upstream activator of p38 MAP kinases and c-Jun . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
BloodHome page
C.-L. Chen, C.-F. Lin, W.-T. Chang, W.-C. Huang, C.-F. Teng, and Y.-S. Lin
Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway
Blood, April 15, 2008; 111(8): 4365 - 4374.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Tao, X. Jiao, E. Gao, W. B. Lau, Y. Yuan, B. Lopez, T. Christopher, S. P. RamachandraRao, W. Williams, G. Southan, et al.
Nitrative Inactivation of Thioredoxin-1 and Its Role in Postischemic Myocardial Apoptosis
Circulation, September 26, 2006; 114(13): 1395 - 1402.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. B. Arnold, K. Ketterer, J. Kleeff, H. Friess, M. W. Buchler, and M. Korc
Thioredoxin Is Downstream of Smad7 in a Pathway That Promotes Growth and Suppresses Cisplatin-Induced Apoptosis in Pancreatic Cancer
Cancer Res., May 15, 2004; 64(10): 3599 - 3606.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
X. He, Y. Liu, V. Sharma, R. T. Dirksen, R. Waugh, S.-S. Sheu, and W. Min
ASK1 Associates with Troponin T and Induces Troponin T Phosphorylation and Contractile Dysfunction in Cardiomyocytes
Am. J. Pathol., July 1, 2003; 163(1): 243 - 251.
[Abstract] [Full Text] [PDF]